U-Blot® Research Grade Anti-SARS-CoV-2 RBD antibody (B38)Cat. No. WA2380$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-SARS-CoV-2 RBD antibody (B38)Cat. No. WA2380
U-Blot® Research Grade Anti-SARS-CoV-2 RBD Antibody (6D60)Cat. No. WA2379
U-Blot® Research Grade Anti-SARS-CoV-2 RBD Antibody (3-2A2-4)Cat. No. WA2378
U-Blot® Research Grade Anti-SARS-CoV-2 RBD (S304)Cat. No. WA2377
U-Blot® Research Grade Anti-SARS-CoV-2 RBD (S2M11)Cat. No. WA2376
U-Blot® Research Grade Anti-SARS-CoV-2 RBD (COV44-79)Cat. No. WA2375
U-Blot® Research Grade Anti-SARS-CoV-2 RBD (COV44-62)Cat. No. WA2374
U-Blot® Research Grade Anti-SARS-CoV-2 RBD (C1)Cat. No. WA2373
U-Blot® Research Grade Anti-SARS-CoV-2 RBD (Beta-27 Fab)Cat. No. WA2372
U-Blot® Research Grade Anti-SARS-CoV-2 RBD (ADI-62113)Cat. No. WA2371
U-Blot® Research Grade Anti-SARS-CoV-2 RBD (6M6)Cat. No. WA2370
U-Blot® Research Grade Anti-SARS-CoV-2 NTD Protein (CV3-13)Cat. No. WA2369